The growth of the auto injector industry has been driven largely in part by the need to improve patient compliance …

Riding high of the success of its new lung drug Esbriet, InterMune has become the focus of some serious takeover …

Vertex will stop selling its once-blockbuster hepatitis C drug in the US this autumn after being crushed by new therapies. …

Amgen’s new rare cancer drug has failed in a late-stage trial just a year after the US biotech spent $10.4 …

Niklas Prager has been named as the new president and chief executive of Sweden-based pharma firm Medivir. Starting in September, …

Samedan Pharmaceutical Publishers has appointed two editorial and production assistants to join Pharmafile and Pharmafocus. Tom Robinson (pictured right) joins Pharmafile …

Mobile healthcare firm Safe Patient Systems is partnering with NHS Greater Glasgow and Clyde (NHSGGC) to provide mobile healthcare services …

Pfizer and genetics testing firm 23andMe have come together in a research pact aimed at finding the genetic cause of …

Sanofi could pay out as much as $925 million for global rights to the world’s only approved inhaled insulin just …

Cancer Research UK is calling upon the medical community to become more involved with Wikipedia to ensure better accuracy of …

The World Health Organization will allow untested treatments for Ebola to be used in West Africa as the death toll …

The NHS spent more than £2.2 million on average every day over the last financial year on diabetes medicines, according …

GlaxoSmithKline faces fresh allegations that it bribed Syrian doctors and officials to boost sales of its medicines in what is …

UK Healthcare consultancy firm Spectrum Regulatory Solutions has appointed two new medical writers to further expand its team. Prior to …

French ophthalmic firm Nicox has confirmed that Dr Adrienne Graves and Luzi von Bidder will be joining its board of …

Clinical trials of an experimental vaccine against the deadly Ebola virus will begin soon according to its developers GlaxoSmithKline. The …

US biopharma firm Synta Pharmaceuticals has confirmed that Anne Whitaker is joining the company as president and chief executive. Whitaker …

A private investigator hired by GlaxoSmithKline to look into the secret recording of a sex tape of its China boss …

Digital technology is moving on apace, but is the pharma industry keeping up and just what are the opportunities to …

Cancer Research UK and its commercial arm, Cancer Research Technology (CRT) have announced they are joining forces with Astellas in …